Mutz Christopher 4
4 · ANI PHARMACEUTICALS INC · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Mutz Christopher
HEAD OF RARE DISEASE
Transactions
- Sale
Common Stock
2024-11-15$57.70/sh−6,500$375,050→ 76,777 total
4 · ANI PHARMACEUTICALS INC · Filed Nov 18, 2024
Common Stock